Nasdaq

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...
Nasdaq

Abbott Announces FDA Approval For Tendyne Transcatheter Mitral Valve Replacement System

(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TMVR) system to ...
Hosted on MSN

New Mitral Valve Replacement Device Wins FDA Approval

In another news, a new device Tendyne transcatheter mitral valve replacement (TVMR) system has been approved by the US Food and Drug Administration (FDA) for the treatment for patients who are ...
TCTMD

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Among patients with either severe symptomatic mitral regurgitation (MR) or with severe mitral annular calcification (MAC) who are deemed too high risk for surgery but eligible for MitraClip (Abbott), ...
Hosted on MSN

Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio

Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) system, the first device of its kind approved in the US to treat mitral ...